Sabine Inghelbrecht

Title: Sabine Inghelbrecht: Innovator in Pharmaceutical Compositions

Introduction

Sabine Inghelbrecht is a notable inventor based in Stekene, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions containing Ibrutinib. Her work is crucial in addressing various B-cell proliferative disorders.

Latest Patents

Inghelbrecht holds 1 patent related to pharmaceutical compositions that include Ibrutinib. This patent discusses the formulations and processes for preparing these compositions, which are designed for oral ingestion. The compositions can be utilized in treating conditions such as non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia, among others. The formulations may be contained within capsules or in liquid form, showcasing her innovative approach to drug delivery.

Career Highlights

Sabine Inghelbrecht is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. Her work at Janssen has allowed her to focus on developing effective treatments for serious health conditions, contributing to advancements in medical science.

Collaborations

Throughout her career, Inghelbrecht has collaborated with esteemed colleagues, including Dilip J. Gole and Maristella Bernini. These collaborations have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Sabine Inghelbrecht's contributions to pharmaceutical compositions highlight her role as an innovator in the industry. Her work continues to impact the treatment of critical health conditions, showcasing the importance of innovation in medicine.